Ithaka Partners - Investor Profile and Portfolio

Online retailer of used and new cars with financing options. The platform provides tools for comparing vehicles, estimating loan payments, and finding dealerships. It offers vehicle reviews, buying guides, and resources for selling cars. The site also provides vehicle history reports and deal ratings.

Provider of plant-based nutrition drinks. The company offers plant-based drinks for adults and children that are designed for improved tolerance with organic ingredients including pea protein for digestion, phytonutrients, and prebiotic fiber. The product is claimed to be prepared from dairy-free, gluten-free, and soy-free ingredients such as brown rice syrup, organic sunflower oil, and pea proteins.

Developer of sustainable solid-state batteries. Its various applications, including electric vehicles, homes, and critical infrastructure. Its battery technology is designed to be safe, sustainable, and scalable.

Biotech combating antimicrobial resistance through innovative therapies and novel mechanisms. The company is dedicated to eliminating the threat of current and emergent antimicrobial resistance across a wide range of infectious diseases. They are researching new classes of anti-resistance agents that employ novel mechanisms of action, focusing on disrupting the foundation of bacterial cell wall architecture. Their approach targets the very foundation of bacterial survival, dismantling cellular infrastructure and disrupting mechanisms that fuel antimicrobial resistance. They are developing therapies to combat antimicrobial resistance, going beyond traditional methods. Their pipeline includes FtsZ Inhibitors, Efflux Pump Inhibitors (EPIs), and Dihydrofolate Reductase Inhibitors (DHFRIs). They aim to enhance existing antibiotics by inhibiting efflux pumps in multidrug-resistant bacteria. Their research and development efforts are supported by grants and aim to provide a robust defense against future resistance.